NCT03436901View on ClinicalTrials.gov

Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

October 1, 2021

Conditions
Testicular Neoplasm
Interventions
DIAGNOSTIC_TEST

MRI with DWI vs CT

MRI with diffusion weighted imaging of thorax, abdomen, and pelvis without contrast agent vs. CT of thorax, abdomen, and pelvis with contrast agent

Trial Locations (1)

8200

Aarhus University Hospital, Dept Radiology, Aarhus

All Listed Sponsors
lead

Aarhus University Hospital

OTHER

NCT03436901 - Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III | Biotech Hunter | Biotech Hunter